Physician profile
Shane Gerber
NPI 1548309503
$1,560.58
in general payments reported to CMS, 2019-2025
14 companies · $283 in 2025
The $283 reported for 2025 was more than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $398 · 2022: $244 · 2023: $472 · 2024: $163 · 2025: $283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $500 · Education: $418.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $500.03 |
| Education | $417.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $557.18 | 2023-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $460.76 | 2021-2025 | |
| Therapeuticsmd, INC. | $135.49 | 2021-2022 | |
| Exeltis, USA INC. | $112.38 | 2021-2025 | Slynd |
| Sumitomo Pharma America, INC. | $99.95 | 2024-2025 | Myfembree, Gemtesa |
| Novo Nordisk INC | $52.42 | 2021-2025 | Wegovy |
| Avion Pharmaceuticals | $38.31 | 2021-2022 | |
| Boston Scientific Corporation | $27.80 | 2025 | Axonics |
| Agile Therapeutics, INC. | $16.11 | 2022 | |
| Currax Pharmaceuticals LLC | $14.43 | 2024 | Contrave |
| Hologic Sales and Service, LLC | $12.92 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.46 | 2021 | |
| Daiichi Sankyo INC. | $12.30 | 2022 | |
| Organon LLC | $8.07 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shane Gerber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.